US-based MetLife is considering the sale of its Ukrainian subsidiary, in a deal that could be valued at more than $100mn, reported Ukraine Business News.

The unit, which has operated in Ukraine since 2002, is the country’s largest life insurer and one of its most profitable financial institutions. While no official confirmation has been issued, several potential buyers have already expressed interest, including Uniqa, TAS Life and PZU Ukraine.

According to 2025 results, the Ukrainian arm of MetLife reported assets of UAH11.4bn ($263mn) and net profit of nearly UAH1bn. Life insurance premiums totalled around UAH3bn, with individuals accounting for the bulk of policies.

Analysts estimate the potential deal value could range from $90mn to $220mn, depending on valuation methodology and transaction structure. One key benchmark is the company’s equity, which stands at approximately 4.9bn hryvnias, or over $110mn.

The possible sale comes as MetLife reviews its global footprint, with sources pointing to a strategic reassessment of operations in smaller markets. Demographic pressures in Ukraine, including a shrinking and ageing population exacerbated by the war, are also seen as a factor weighing on long-term growth prospects.

If completed, the transaction would mark one of the most significant developments in Ukraine’s insurance sector in recent years, where consolidation and foreign investor participation have been reshaping the competitive landscape.